EGFR and lung adenocarcinoma: In lung adenocarcinoma, the most extensively investigated somatic mutations in EGFR are deletions in exon19 (dels746–750) or a replacement of leucine by arginine at codon 858 in exon 21 (L858R), leading to tremendous contributions to clinical practice [13,14].